BioSpace News Archive

Pharm Country

Cigna Health Services Business Pioneers an Innovative Solution to Affordably Bring Life-Changing Therapies to Patients

Breakthrough, potentially life-changing medicines offer great promise for patients and their families. However, the high prices of the medicines – millions of dollars in some cases – threaten coverage and access by patients who may benefit.

September 5, 2019
·
5 min read
CollPlant Biotechnologies to Present at the 21st Annual Rodman & Renshaw Global Investment Conference

CollPlant announced that Yehiel Tal, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in New York on Tuesday, September 10th, 2019 at 1:45 pm EDT.

September 5, 2019
·
4 min read
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

Crescita Therapeutics Inc. announced that its executive chairman, Dan Chicoine will be presenting at this year’s Fall Investor Summit on Monday, September 16th at 1:00 p.m. eastern time in New York City.

September 5, 2019
·
1 min read
Bio NC

Altavant Sciences Presents Patient-Centric Approach to Drug Development at PHA’s Annual PHPN Symposium

Altavant Sciences announced a poster presentation describing the company’s unique, patient-centric drug development process at the Pulmonary Hypertension Association’s Annual PH Professional Network Symposium taking place September 5-7, 2019 in Washington, D.C.

September 5, 2019
·
3 min read
Business

SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors

SmartPharm Therapeutics announced the appointment of Fred Driscoll to its Board of Directors.

September 5, 2019
·
2 min read
Business

IFM Therapeutics Announces Collaboration and Exclusive Option Agreement for cGAS/STING-Focused Subsidiary, IFM Due

Agreement provides funding for research and development costs through late-stage preclinical development of lead program with option to acquire IFM Due

September 5, 2019
·
5 min read
Endo to Present New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 American Society for Surgery of the Hand’s (ASSH) Annual Meeting

Endo International plc announced that four new studies of XIAFLEX®, including real-world data, for the treatment of Dupuytren’s contracture will be presented as ePosters at the 74th Annual Meeting of the American Society for Surgery of the Hand in Las Vegas, Nevada, September 5 - 7, 2019.

September 5, 2019
·
6 min read
BioCapital

CASI Pharmaceuticals, Inc. to Host Key Opinion Leader Symposium on September 10, 2019 in New York City

CASI Pharmaceuticals, Inc. announces it will host a key opinion leader symposium addressing innovations in cancer immunotherapy and recent regulatory reforms impacting the China biopharmaceutical market.

September 5, 2019
·
9 min read
Business

Schrödinger Announces Expansion of Multi-Target Research Collaboration with Takeda and Achievement of First Significant Preclinical Milestone in Lead Program

Schrödinger announced the expansion of its multi-year, multi-target drug discovery collaboration with Takeda, as well as Schrödinger’s achievement of the first significant preclinical milestone for the collaboration’s most advanced program.

September 5, 2019
·
2 min read
Business

ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform

JSR Life Sciences Companies Selexis SA and KBI Biopharma, Inc. have announced a new collaboration with ZyVersa Therapeutics to advance development of ZyVersa’s lead inflammasome inhibitor, IC 100, for the treatment of multiple inflammatory conditions.

September 5, 2019
·
5 min read